Head-to-head dispatch
RestorLife Med vs Signos
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
RestorLife Med is a physician-guided GLP-1 telehealth practice (founder Dr.
$199/mo (6-month plan, compounded) sema · Verified August 1, 2026
Marked down on: The advertised $299 is a struck-through anchor price, not a starting point: the real month-to-month rate is $299, a first month runs $149 at 50% off, and the $199 rate needs six months
Desk Score
Signos (Signos+) is a metabolic-health platform that bundles clinician-prescribed compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor (CGM) and app.
$199/mo (6-month plan, compounded) sema · $199/mo (starting dose, compounded) tirz · Verified July 25, 2026
Marked down on: Compounded GLP-1s are not FDA-approved finished products
RestorLife Med takes this head-to-head with the higher Desk Score, 77/100 (C+) against 62/100 (C) for Signos. Signos still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
RestorLife Med
77/100
C+
Signos
62/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | RestorLife Med | Signos |
|---|---|---|
| Semaglutide | $199/mo (6-month plan, compounded) | $199/mo (6-month plan, compounded) |
| Tirzepatide | Not listed on RestorLife Med's site (checked August 1, 2026) | $199/mo (starting dose, compounded) |
| Coverage | All 50 states | Not listed on Signos's site (checked July 25, 2026) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | GLP-1 weight care from a named board-certified physician, with microdosing and strong clinical support. | Pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app. |
| Desk Score | 77/100C+ | 62/100C |
The verdict
Desk pick — RestorLife MedRestorLife Med takes this head-to-head with the higher Desk Score, 77/100 (C+) against 62/100 (C) for Signos. Signos still holds its ground where its strengths line up with yours.
Choose RestorLife Med if…
GLP-1 weight care from a named board-certified physician, with microdosing and strong clinical support.
$199/mo (6-month plan, compounded) sema · All 50 states
Choose Signos if…
Pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app.
$199/mo (6-month plan, compounded) sema · $199/mo (starting dose, compounded) tirz
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: RestorLife Med · Signos.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- RestorLife Med vs CoreAge Rx
- Signos vs Vaylen
- RestorLife Med vs Strut Health
- Signos vs Ondra Health
- RestorLife Med vs Invigor Medical
- Signos vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.